Can LivaNova cover its short-term obligations?

Its current ratio is 1.33 — current assets exceed current liabilities.

Where does LivaNova's balance sheet data come from?

Every line is extracted from LivaNova's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

LivaNova LIVN Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$635.55M-12.2%	$723.56M+25.2%	$577.87M+12.1%	$515.62M+148%
Accounts receivable, net	$215.99M+11.8%	$193.16M-10.2%	$215.07M+17.5%	$183.11M-1.2%
Inventories	$164.7M+11.6%	$147.57M-0.2%	$147.89M+14.3%	$129.38M+22.2%
Raw materials	$75.8M+5.4%	$71.95M-12.1%	$81.88M+16.9%	$70.03M+59.3%
Work in process	$12.88M+4.5%	$12.32M-4.5%	$12.9M-16.8%	$15.51M+9.5%
Finished goods	$76.03M+20.1%	$63.3M+19.2%	$53.11M+21.1%	$43.84M-8.1%
Prepaid expenses and other current assets	$36.77M+13.6%	$32.36M+19.1%	$27.18M+3.3%	$26.32M-26.4%
Income taxes receivable	$48.61M+59.1%	$30.54M+51.6%	$20.15M-36.5%	$31.71M-15.7%
Total current assets	$1.1B-2.3%	$1.13B+14.1%	$988.16M+11.5%	$886.14M+30.5%
Property and equipment, net	$242.6M+42.5%	$170.26M+10.4%	$154.18M+4.8%	$147.19M-1.9%
Operating lease right-of-use assets	$55.52M+18.5%	$46.84M-7.9%	$50.85M+41.9%	$35.83M-11.7%
Goodwill	$792.84M+5.7%	$750.01M-4.2%	$782.94M+1.8%	$768.79M-14.5%
Intangible assets, net	$229.96M-3.1%	$237.29M-9.1%	$261.18M-29.1%	$368.56M-7.8%
Deferred tax assets	$9.59M-12.1%	$10.92M-5.6%	$11.57M+35.8%	$8.52M+10.2%
Other non-current assets	$15.69M+11.0%	$14.13M+17.2%	$12.06M-25.7%	$16.23M+23.9%
Equity method investments	$20.29M-19.1%	$25.08M—	——	——
Available-for-sale securities	$3M—	——	——	——
Total assets	$2.61B+4.0%	$2.51B+3.2%	$2.43B+5.9%	$2.29B+4.3%
Accounts payable	$97.16M+39.3%	$69.73M-13.8%	$80.85M+8.8%	$74.31M+9.3%
Accrued expenses	$94.57M-20.2%	$118.49M+10.4%	$107.3M+31.7%	$81.48M-8.4%
Accrued compensation	$92.91M+15.4%	$80.54M-14.9%	$94.63M+31.1%	$72.19M-8.9%
Deferred revenue	$11.51M+6.1%	$10.85M+1.1%	$10.73M+4.9%	$10.23M+21.5%
Current portion of long-term debt	$30.88M-60.1%	$77.34M+342%	$17.48M-16.3%	$20.89M-90.8%
Operating lease liabilities, current	$8.79M-2.8%	$9.04M+8.1%	$8.36M-10.8%	$9.38M-16.7%
Contract liabilities	$17.9M+21.8%	$14.7M-3.9%	$15.3M+8.5%	$14.1M+43.9%
Income taxes payable	$33.13M+2.1%	$32.46M+39.1%	$23.34M+41.4%	$16.51M+9.0%
Accrued interest	$4.64M-51.1%	$9.48M—	——	——
Total current liabilities	$808.07M+106%	$392.13M+17.1%	$334.98M+12.6%	$297.4M-57.3%
Long-term debt	$345.19M-37.2%	$549.62M-3.3%	$568.54M+9.7%	$518.07M+5,160%
Operating lease liabilities, non-current	$48.33M+20.5%	$40.11M-11.6%	$45.39M+53.6%	$29.55M-17.7%
Other non-current liabilities	$55.37M+24.5%	$44.48M-6.8%	$47.73M+4.1%	$45.85M-8.1%
Total liabilities	$176.08M-85.2%	$1.19B+3.0%	$1.15B+6.0%	$1.09B+20.0%
Common stock	$84.56M+1.7%	$83.16M+0.8%	$82.53M+0.1%	$82.42M+0.2%
Additional paid-in capital	$2.25B+1.5%	$2.22B+1.4%	$2.19B+1.5%	$2.16B+1.9%
Retained earnings	-$1.15B-26.8%	-$903.25M+6.5%	-$966.48M+1.8%	-$984.03M-9.6%
Accumulated other comprehensive income (loss)	$7.33M+109%	-$80.17M-188%	-$27.88M+42.1%	-$48.12M-570%
Treasury stock	$1.17M+757%	$136K+147%	$55K-85.3%	$375K-42.3%
Total stockholders' equity	$1.2B-9.1%	$1.32B+3.3%	$1.28B+5.8%	$1.21B-6.7%
Total liabilities and stockholders' equity	$2.61B+4.0%	$2.51B+3.2%	$2.43B+5.9%	$2.29B+4.3%
Allowance for Doubtful Accounts	$12.53M+11.1%	$11.28M-6.2%	$12.02M+1.3%	$11.86M-12.2%
Allowance for Doubtful Accounts Receivable (Current)	$12.53M+11.1%	$11.28M-6.2%	$12.02M+1.3%	$11.86M-12.2%
Finished goods	$76.03M+20.1%	$63.3M+19.2%	$53.11M+21.1%	$43.84M-8.1%
Derivative Assets - Fair Value	$36.55M+54.0%	$23.74M-38.3%	$38.5M-30.9%	$55.73M-47.9%
Other Inventory, Net	$18M+9.8%	$16.4M-32.8%	$24.4M+198%	$8.2M-7.9%
Deferred Tax Assets and Other Non-Current Assets	$15.69M+11.0%	$14.13M+17.2%	$12.06M-25.7%	$16.23M+23.9%
Derivative Assets, Non-Current	$36.55M+54.0%	$23.74M-38.3%	$38.5M-29.2%	$54.39M—
Net Investment in Lease	$55.52M+18.5%	$46.84M-7.9%	$50.85M+41.9%	$35.83M-11.7%
Deferred tax assets	$110.98M-0.8%	$111.86M-5.9%	$118.86M+8,488%	$1.38M-37.0%
Other intangible assets—net	$229.96M-3.1%	$237.29M-9.1%	$261.18M-29.1%	$368.56M-7.8%
Investments	$20.29M-19.1%	$25.08M—	——	——
Operating lease right-of-use assets	$55.52M+18.5%	$46.84M-7.9%	$50.85M+41.9%	$35.83M-11.7%
Other non-current assets	$15.69M+11.0%	$14.13M+17.2%	$12.06M-25.7%	$16.23M+23.9%
Operating Lease Right-of-Use Assets in Other Assets	$55.52M+18.5%	$46.84M-7.9%	$50.85M+41.9%	$35.83M-11.7%
Software and Technology Licenses, Net	$15.69M+11.0%	$14.13M+17.2%	$12.06M-25.7%	$16.23M+23.9%
Accrued Contingent Liabilities	——	——	——	——
Accrued Environmental Liabilities	$396.24M—	$0—	——	——
Accrued Litigation	$12.55M-2.8%	$12.92M+20.1%	$10.76M-63.5%	$29.48M-10.2%
Accrued Royalties (Current)	$4.76M+6.5%	$4.47M+0.6%	$4.44M+12.4%	$3.95M—
Other Commercial Liabilities	$94.57M-20.2%	$118.49M+10.4%	$107.3M+31.7%	$81.48M-8.4%
Accrued Liabilities, Current	$94.57M-20.2%	$118.49M+10.4%	$107.3M+31.7%	$81.48M-8.4%
Derivative Liability, Current	$99K-96.6%	$2.92M-24.9%	$3.88M-34.0%	$5.89M-96.8%
Derivative Liabilities - Fair Value	$99K-96.6%	$2.92M-24.9%	$3.88M-34.0%	$5.89M-96.8%
Professional Service Fees Payable	$18.4M+5.9%	$17.38M-2.3%	$17.79M+106%	$8.65M-26.9%
Contingent Consideration Liability (Non-Current)	$42.05M-50.1%	$84.22M+4.1%	$80.9M-5.1%	$85.29M-1.8%
Defined Benefit Pension Plan Liabilities (Non-Current)	$13.57M+5.7%	$12.85M-25.5%	$17.25M+2.7%	$16.8M-12.0%
Derivative Liabilities (Non-Current)	$83.9M+61.9%	$51.82M+13.7%	$45.57M-46.8%	$85.68M—
Non-current Loss Contingency Accrual	——	——	——	——
Accrued litigation	$12.55M-2.8%	$12.92M+20.1%	$10.76M-63.5%	$29.48M-10.2%
Retirement and nonpension postretirement benefit obligations	$13.57M+5.7%	$12.85M-25.5%	$17.25M+2.7%	$16.8M-12.0%
Total debt	$433.18M-35.9%	$676.11M+5.7%	$639.78M+10.7%	$577.89M+103%
Common Stock Par Value Per Share	10.0%	10.0%	10.0%	10.0%
Common Stock Shares Issued	55.5M+2.0%	54.4M+0.9%	53.9M+0.2%	53.9M+0.2%
Additional paid-in capital	$2.25B+1.5%	$2.22B+1.4%	$2.19B+1.5%	$2.16B+1.9%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$84.56M+1.7%	$83.16M+0.8%	$82.53M+0.1%	$82.42M+0.2%
Accrued Environmental Loss Contingencies, Current	$396.24M—	$0—	——	——
Professional service fees	$18.4M+5.9%	$17.38M-2.3%	$17.79M+106%	$8.65M-26.9%
Licensing Arrangements	$4.76M+6.5%	$4.47M+0.6%	$4.44M+12.4%	$3.95M—
Allowance for doubtful accounts	$12.53M+11.1%	$11.28M-6.2%	$12.02M+1.3%	$11.86M-12.2%
Business Combination, Contingent Consideration, Liability	$92.08M+9.3%	$84.22M+4.1%	$80.9M-5.1%	$85.29M-1.8%
Common stock, par value (in dollars per share)	$10.0%	$10.0%	$10.0%	$10.0%
Common stock, shares issued (in shares)	$55.54M+2.0%	$54.44M+0.9%	$53.94M+0.2%	$53.85M+0.2%
Common Stock, Shares, Outstanding	$54.65M+0.6%	$54.35M+0.8%	$53.92M+0.7%	$53.56M+0.6%
Contract with Customer, Liability	$17.9M+21.8%	$14.7M-3.9%	$15.3M+8.5%	$14.1M+43.9%
Short-term debt and current portion of long-term debt	$31.47M-59.7%	$78M+331%	$18.11M-22.7%	$23.43M-89.8%
Estimated Fair Value	$3M—	——	——	——
Deferred income taxes	$9.59M-12.1%	$10.92M-5.6%	$11.57M+35.8%	$8.52M+10.2%
Derivatives	$36.55M+54.0%	$23.74M-38.3%	$38.5M-29.2%	$54.39M—
Derivative Liability, Noncurrent	$83.9M+61.9%	$51.82M+13.7%	$45.57M-46.8%	$85.68M—
Imposed cost	——	——	——	——
Italian MedTech payback measure	$12.84M-19.7%	$15.98M+94.3%	$8.22M+28.2%	$6.41M—
Other accrued liabilities	$26.99M-19.3%	$33.46M+36.9%	$24.45M-6.8%	$26.23M+3.3%
Provisions for agents, returns, and other	$5.32M-21.1%	$6.74M+51.1%	$4.46M+166%	$1.68M-33.8%
Research and development costs	$1.23M-80.0%	$6.17M+150%	$2.46M-64.9%	$7.02M+31.7%
Treasury stock, shares (in shares)	$886.1K+894%	$89.13K+272%	$23.93K-91.7%	$287.32K-42.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Can LivaNova cover its short-term obligations?: Its current ratio is 1.33 — current assets exceed current liabilities.
Where does LivaNova's balance sheet data come from?: Every line is extracted from LivaNova's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.